Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical cancer among patients in Delta Region, Egypt Authors: Thabet M, Hemida R, Hasan M, Elshamy M, Elfaraash M, Emam M. Abstract BACKGROUND: Cervical cancer remains a significant problem worldwide particularly in underdeveloped countries. It is necessary to have a persistent infection of the […]
Human Papillomavirus in Infants: Transmission, HPV Prevalence, and Persistence
HPV Prevalence, and Persistence Author: Delese E. LaCour, MD* Introduction HPV prevalence. Infections caused by human papillomavirus (HPV) result in considerable morbidity and mortality throughout the world.1–4 Conditions such as anogenital warts, caused by low-risk HPV genotypes and cervical dysplasia, more commonly caused by oncogenic HPV types, can affect females in all age groups.5–9 The prevalence […]
HPV prevalence and pre-cancer and cancer risk in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs
Cancer Risk Authors: Cinzia Campari12, Chiara Fedato3, Alessio Petrelli4, Manuel Zorzi5, Carla Cogo5, Adele Caprioglio6, Federica Gallo6, Livia Giordano6, Serena Domenighini7, Luigi Pasquale7, Sonia Prandi8, Marco Zappa9, Paolo Giorgi Rossi102* and the GISCi Migrant Working Group Abstractᅟ Immigrants from low- and medium-income countries have a higher risk of cervical cancer due both to barriers in access […]
HPV genotype distribution in cervical, vulvar and vaginal disease
Global availability of data on HPV genotype distribution in cervical, vulvar and vaginal disease and genotype specific prevalence and incidence of HPV infection in females Authors: Monika Wagner1*, Liga Bennetts1, Harshila Patel1, Sharon Welner1, Silvia de Sanjose34 andThomas W Weiss2 Abstract (provisional) Background Country-level HPV genotyping data may be sought by decision-makers to gauge the genotype […]
Cytokine levels in cervical cancers: HPV 16-18 vs non HPV 16-18 genotypes
IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16-18 vs. non-HPV16-18 genotypes By Adriana C Vidal1, David Skaar2, Rachel Maguire2, Seyram Dodor3, Laura W Musselwhite4, John A Bartlett5, Olola Oneko6, Joseph Obure6, Pendo Mlay6, Susan K Murphy7 and Cathrine Hoyo2* Abstract Background Despite comparable screening rates for precancerous lesions, […]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 14
- Next Page »
